×
About 2,730 results

ALLMedicine™ Hirsutism Center

Research & Reviews  805 results

Depression symptoms and quality of life in women with polycystic ovary syndrome.
https://doi.org/10.1111/ppc.13131
Perspectives in Psychiatric Care; Kocak DY, Ugurlu M

Jun 24th, 2022 - To determine depression symptoms and quality of life in women with polycystic ovary syndrome (PCOS). The data were collected using the Participant Information Form, PCOS Quality of Life Questionnaire (PCOSQ-50), and Beck Depression Inventory (BDI)...

17-Hydroxyprogesterone, Urine
https://emedicine.medscape.com/article/2097997-print

Jun 23rd, 2022 - The reference range of urinary 17-hydroxyprogesterone (17-OHPG) in children is as follows:[1, 2, 3] Age 3 days to 1 year: Up to 50 ng/24 hours Age 1-8 years: Up to 300 ng/24 hours The following is the reference of urinary 17-OHPG in adults: Males:...

17-Hydroxyprogesterone, Urine
http://emedicine.medscape.com/article/2097997-overview

Jun 23rd, 2022 - Reference Range The reference range of urinary 17-hydroxyprogesterone (17-OHPG) in children is as follows: [1, 2, 3] Age 3 days to 1 year: Up to 50 ng/24 hours Age 1-8 years: Up to 300 ng/24 hours The following is the reference of urinary 17-OHPG ...

17-Hydroxyprogesterone, Urine
https://emedicine.medscape.com/article/2097997-overview

Jun 23rd, 2022 - Reference Range The reference range of urinary 17-hydroxyprogesterone (17-OHPG) in children is as follows: [1, 2, 3] Age 3 days to 1 year: Up to 50 ng/24 hours Age 1-8 years: Up to 300 ng/24 hours The following is the reference of urinary 17-OHPG ...

Hair and Nail Conditions: Hypertrichosis and Hirsutism.
https://www.ncbi.nlm.nih.gov/pubmed/35679469
FP Essentials; Vedak P

Jun 10th, 2022 - Hypertrichosis and hirsutism can be signs of underlying conditions, some of which may be life-threatening. They also can result in significant psychosocial distress for patients. Hypertrichosis refers to excessive hair growth beyond normal variati...

see more →

Guidelines  3 results

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clin...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.

Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...

see more →

Drugs  25 results see all →

Clinicaltrials.gov  103 results

Sexual Dysfunction in Infertile Women With PCOS Undergoing Fertility Treatment
https://clinicaltrials.gov/ct2/show/NCT05402800

Jun 2nd, 2022 - Our work is an observational analytic cross-sectional study that included an Egyptian convenient sample of 186 females with primary infertility due to polycystic ovary syndrome. Patients aged 18-35 were recruited from Kasr Al-Ainy Gynecology Clini...

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
https://clinicaltrials.gov/ct2/show/NCT04831151

May 19th, 2022 - Polycystic ovary syndrome (PCOS), is the most common endocrinological disorder that affects the reproductive aged women. In addition to causing problems such as menstrual irregularity, hirsutism, acne, it is also an important health problem that c...

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
https://clinicaltrials.gov/ct2/show/NCT01889199

May 18th, 2022 - Aim 1. Examine mechanisms of subcutaneous abdominal adipose (fat) development in normal-weight PCOS women vs. BMI- and age-matched normal (control) women. Subjects and clinical assessment: We will recruit 16 lean (18.5-25 kg/M2) PCOS subjects and ...

Lifestyle Change in Women With Polycystic Ovary Syndrome
https://clinicaltrials.gov/ct2/show/NCT05377021

May 17th, 2022 - This project aims to compare "diet" and "diet and exercise combination" interventions in obese women with polycystic ovary syndrome. This project will be carried out in the Dokuz Eylül University Research and Application Hospital gynecology outpat...

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
https://clinicaltrials.gov/ct2/show/NCT04381897

May 16th, 2022 - Cornelia de Lange syndrome (CdLS) is a genetic condition caused by mutations in cohesin-related genes, mostly notably NIPBL. The CdLS phenotype includes physical features such as typical facies, limb abnormalities, short stature, and hirsutism as ...

see more →

News  146 results

PCOS comes with high morbidity, medication use into late 40s
https://www.mdedge.com/obgyn/article/255294/gynecology/pcos-comes-high-morbidity-medication-use-late-40s
Marcia Frellick

Jun 8th, 2022 - Women with polycystic ovary syndrome (PCOS) have an increased risk for several diseases and symptoms, many independent of body mass index (BMI), new research indicates. Some diseases are linked for the first time to PCOS in this study, the authors.

Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
https://www.mdedge.com/dermatology/article/252003/acne/spironolactone-not-linked-increased-cancer-risk-systematic-review
Christine Kilgore

Feb 22nd, 2022 - Spironolactone was not associated with any meaningful increase in the risk of breast cancer or other solid organ cancers in a systematic review and meta-analysis covering seven observational studies and a total population of over 4. 5 million peopl.

Dramatic Increase in Response With Combination for Relapsed/Resistant ITP
https://www.medpagetoday.com/hematologyoncology/hematology/96918

Jan 28th, 2022 - Patients with relapsed or corticosteroid-resistant immune thrombocytopenia (ITP) had a 33% higher response rate and 50% increase in sustained responses with all-trans retinoic acid (ATRA) plus low-dose rituximab (Rituxan), Chinese investigators re...

FDA Approves Levoketoconazole for Cushing Syndrome
https://www.medscape.com/viewarticle/965989

Jan 4th, 2022 - The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not possible or was not curative. Endogenous Cushin...

FDA OKs First Proteinuria Drug for IgA Nephropathy
https://www.medpagetoday.com/nephrology/generalnephrology/96235

Dec 16th, 2021 - The FDA granted accelerated approval for the first drug to reduce proteinuria in primary immunoglobulin A (IgA) nephropathy, the agency announced on Wednesday. The delayed released budesonide (Tarpeyo) capsules are indicated to lower increased pro...

see more →

Patient Education  10 results see all →